Table II.
Summary of reported pharmacokinetic studies assessing steady state N-acetylcysteine concentrations in humans.
| Reference | Patient group | Route of administration | Steady state plasma concentration (μM) |
|---|---|---|---|
| Ahola et al (1999) | Pre-term newborns | IV | 510 |
| Borgstrom et al (1986) | Pediatric | IV | 400 |
| Adult | IV | 200 | |
| Brown et al (2004) | Adult | IV | 930 |
| Jones et al (1997) | Adult | IV | 210 |
| Olsson et al (1988) | Adult | IV | 37 |
| Prescott et al (1989) | Adult | IV | 230 |
| De Caro et al (1989) | Adult | PO (single 600 mg dose) | 33 |
| Holdiness (1991) | Adult | PO | 65 |
IV Intravenous; PO Oral. Adapted from Chen, et al (2007), with permission.